the need for better surrogate parameters for overall survival in colorectal cancer
Published 7 years ago • 54 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:10
targeted therapies improve overall survival for patients with sub type of colorectal caner
-
2:23
biomarker testing and targeted therapies in colorectal cancer
-
1:03
advances in targeted therapies for colorectal cancer
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
2:53
the emerging role of mrd in colorectal cancer decision making
-
1:18
dr. heinemann on surrogate markers beyond pfs in patients with crc
-
31:53
lecture 2 - surrogate endpoints in oncology - reading and interpreting cancer trials
-
0:49
novel immunotherapy approaches for mmr-proficient colorectal cancer
-
59:23
iddi webinar: current status of surrogates for survival in cancer trials
-
22:30
new directions in targeting angiogenesis for metastatic colorectal cancer
-
22:10
novel agents and targets in colorectal cancer
-
1:31
targeted therapies showing promise in colorectal cancer
-
19:05
on surrogate endpoints in oncology
-
4:57
case 2: maintenance therapy in mcrc
-
5:54
initial systemic therapy for metastatic colorectal cancer
-
1:03:16
targeted therapies and biomarkers in advanced colorectal cancer - m. s. lee - 20180725
-
3:33
fruquintinib provides improvement in overall survival for refractory mcrc
-
5:12
follow-up after adjuvant therapy for colorectal cancer
-
0:46
dr. s yousuf zafar talks about bmi and survival rates in colorectal cancer patients